Fingerprint
Dive into the research topics of 'Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Gerd R. Burmester, Kevin Winthrop, Ricardo Blanco, Peter Nash, Philippe Goupille, Valderilio F. Azevedo, Carlo Salvarani, Andrea Rubbert-Roth, Elizabeth Lesser, Ralph Lippe, Apinya Lertratanakul, Reva M. Mccaskill, John Liu, Eric M. Ruderman
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations